Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. Almadori A, Griffin M, Ryan CM, Hunt DF, Hansen E, Kumar R, et al.
Date: July 2019. Source: PLoS ONE 14(7): e0218068. https://doi.org/10.1371/journal.pone.0218068 Abstract: Oro-facial fibrosis in systemic sclerosis (Scleroderma;SSc) has a major impact on mouth function, facial appearance, and patient quality of life. Lipotransfer is a method of reconstruction that can be used in the treatment of oro-facial fibrosis. The effect of this treatment not only restores oro-facial […]Read More
The Effect of Lipotransfer on Facial Scleroderma. DF Hunt, LL Bravan, LL Uppal, C Denton, PE Butler.
Date: April 2015. Source: Plastic and Reconstructive Surgery, Volume 135, Issue 4, AAPS Abstract Supplement, p 1181. Purpose: Scleroderma (SS), is a systemic autoimmune disease causing fibrosis of the skin and other tissues. In diffuse cutaneous disease 1—year survival is 55%. Scleroderma commonly affects the face and mouth. Methods: We report the treatment of oral facial […]Read More